Veledimex (S enantiomer) is primarily used in the field of gene therapy, particularly in the regulation of gene expression. It acts as a small-molecule inducer for gene switches, enabling precise control over therapeutic gene activity. This compound is often utilized in conjunction with gene therapy systems like the RheoSwitch Therapeutic System, where it helps activate or deactivate specific genes in response to its presence. Its application is significant in cancer treatment, where it allows for targeted gene expression in tumor cells, minimizing damage to healthy tissues. Additionally, Veledimex (S enantiomer) is being explored in the treatment of genetic disorders and autoimmune diseases, offering a potential pathway for controlled and effective therapeutic interventions.